NR4A2 and schizophrenia: Lack of association in a Portuguese/Brazilian study

American Journal of Medical Genetics - Neuropsychiatric Genetics

Volumn 128 B, Issue 1, 2004, Pages 41-45

  Ruano, Dina ^a,b   Macedo, António ^c   Dourado, Ana ^c   Soares, Maria João ^c   Valente, José ^c   Coelho, Isabel ^c   Santos, Vítor ^c   Azevedo, Maria Helena ^c   Goodman, Ann ^d   Hutz, Mara Helena ^e   Gama, Clarissa ^e   Lobato, Maria Inês ^e   Belmonte De Abreu, Paulo ^e   Palha, Joana Almeida ^a,b  

^a UNIVERSITY OF MINHO   (Portugal)

^b UNIVERSITY OF PORTO   (Portugal)

^c UNIVERSITY OF COIMBRA   (Portugal)

^d HARVARD MEDICAL SCHOOL   (United States)

^e FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

Author keywords

Dopamine; Nuclear orphan receptor; Nurr1; Retinoids

Indexed keywords

NUCLEAR RECEPTOR NR4A2; NUCLEAR RECEPTOR RELATED FACTOR 1; RETINOID X RECEPTOR; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BIPOLAR DISORDER; BRAIN DEVELOPMENT; BRAZIL; CHROMOSOME 2Q; DOPAMINERGIC NERVE CELL; DOPAMINERGIC SYSTEM; FEMALE; GENE EXPRESSION; GENE MAPPING; GENE MUTATION; GENETIC ASSOCIATION; GENETIC LINKAGE; HUMAN; MAJOR CLINICAL STUDY; MALE; PARKINSON DISEASE; PORTUGAL; PRIORITY JOURNAL; SCHIZOPHRENIA;

EID: 3042725449     PISSN: 15524841     EISSN: 1552485X     Source Type: Journal    
DOI: 10.1002/ajmg.b.30031     Document Type: Article

References (35)

1. Balmer JE, Blomhoff R. 2002. Gene expression regulation by retinoic acid. J Lipid Res 43:1773-1808.
2. Buervenich S, Carmine A, Arvidsson M, Xiang F, Zhang Z, Sydow O, Jönsson EG, Sedvall GC, Leonard S, Ross RG, Freedman R, Chowdari KV, Nimgaonkar VL, Perlmann T, Anvret M, Olson L. 2000. NURR1 mutations in cases of schizophrenia and manic-depressive disorder. Am J Med Genet 96:808-813.
3. Bäckman C, You ZB, Perlmann T, Hoffer BJ. 2003. Elevated locomotor activity without altered striatal dopamine contents in Nurr1 heterozygous mice after acute exposure to methamphetamine. Behav Brain Res 143:95-100.
4. Carmine A, Buervenich S, Galter D, Jönsson EG, Sedvall GC, Farde L, Gustavsson JP, Bergman H, Chowdari KV, Nimgaonkar VL, Anvret M, Sydow O, Olson L. 2003. NURR1 promoter polymorphisms: Parkinson's disease, schizophrenia, and personality traits. Am J Med Genet 120: 51-57.
5. Chakravarti A. 1999. Population genetics-making sense out of sequence. Nat Genet 21:56-60.
6. Chen YH, Tsai MT, Shaw CK, Chen CH. 2001. Mutation analysis of the human NR4A2 gene, an essential gene for midbrain dopaminergic neurogenesis, in schizophrenic patients. Am J Med Genet 105:753-757.
7. Citver AS, Shields AM, Ciaccia LM, Schulingkamp RJ, Raffa RB. 2002. Indirect modulation of dopamine D2 receptors as potential pharmacotherapy for schizophrenia: III. Retinoids. J Clin Pharm Ther 27:161-168.
8. DeLisi LE, Mesen A, Rodriguez C, Bertheau A, LaPrade B, Llach M, Riondet S, Razi K, Relja M, Byerley W, Sherrington R. 2002. Genome-wide scan for linkage to schizophrenia in a Spanish-origin cohort from Costa Rica. Am J Med Genet 114:497-508.
9. Eells JB, Lipska BK, Yeung SK, Misler JA, Nikodem VM. 2002. Nurr1-null heterozygous mice have reduced mesolimbic and mesocortical dopamine levels and increased stress-induced locomotor activity. Behav Brain Res 136:267-275.
10. Goodman AB. 1998. Three independent lines of evidence suggest retinoids as causal to schizophrenia. Proc Natl Acad Sci USA 95:7240-7244.
11. Ichinose H, Ohye T, Suzuki T, Sumi-Ichinose C, Nomura T, Hagino Y, Nagatsu T. 1999. Molecular cloning of the human Nurr1 gene: Characterization of the human gene and cDNAs.. Gene 230:233-239.
12. Ishiguro H, Okubo Y, Ohtsuki T, Yamakawa-Kobayashi K, Arinami T. 2002. Mutation analysis of the retinoid X receptor beta, nuclear-related receptor 1, and peroxisome proliferator-activated receptor alpha genes in schizophrenia and alcohol dependence: Possible haplotype association of nuclear-related receptor 1 gene to alcohol dependence. Am J Med Genet 114:15-23.
13. Iwayama-Shigeno Y, Yamada K, Toyota T, Shimizu H, Hattori E, Yoshitsugu K, Fujisawa T, Yoshida Y, Kobayashi T, Toru M, Kurumaji A, Detera-Wadleigh S, Yoshikawa T. 2003. Distribution of haplotypes derived from three common variants of the NR4A2 gene in Japanese patients with schizophrenia. Am J Med Genet 118:20-24.
14. Kim HS, Hong SJ, LeDoux MS, Kim KS. 2001. Regulation of the tyrosine hydroxylase and dopamine beta-hydroxylase genes by the transcription factor AP-2. J Neurochem 76:280-294.
15. Kim KS, Kim CH, Hwang DY, Seo H, Chung S, Hong SJ, Lim JK, Anderson T, Isacson O. 2003. Orphan nuclear receptor Nurr1 directly transactivates the promoter activity of the tyrosine hydroxylase gene in a cell-specific manner. J Neurochem 85:622-634.
16. Le WD, Xu P, Jankovic J, Jiang H, Appel SH, Smith RG, Vassilatis DK. 2003. Mutations in NR4A2 associated with familial Parkinson disease. Nat Genet 33:85-89.
17. Lewis CM, Levinson DF, Wise LH, DeLisi LE, Straub RE, Hovatta I, Williams NM, Schwab SG, Pulver AE, Faraone SV, Brzustowicz LM, Kaufmann CA, Garver DL, Gurling HM, Lindholm E, Coon H, Moises HW, Byerley W, Shaw SH, Mesen A, Sherrington R, O'Neill FA, Walsh D, Kendler KS, Ekelund J, Paunio T, Lönnqvist J, Peltonen L, O'Donovan MC, Owen MJ, Wildenauer DB, Maier W, Nestadt G, Blouin JL, Antonarakis SE, Mowry BJ, Silverman JM, Crowe RR, Cloninger CR, Tsuang MT, Malaspina D, Harkavy-Friedman JM, Svrakic DM, Bassett AS, Holcomb J, Kalsi G, McQuillin A, Brynjolfson J, Sigmundsson T, Petursson H, Jazin E, Zoëga T, Helgason T. 2003. Genome scan meta-analysis of schizophrenia and bipolar disorder, part II: Schizophrenia. Am J Hum Genet 73:34-48.
18. McGuffin P, Farmer A. 2001. Polydiagnostic approaches to measuring and classifying psychopathology. Am J Med Genet 105:39-41.
19. Moises HW, Yang L, Kristbjarnarson H, Wiese C, Byerley W, Macciardi F, Arolt V, Blackwood D, Liu X, Sjogren B, Aschauer HN, Hwu HG, Jang K, Livesley WJ, Kennedy JL, Zoega T, Ivarsson O, Bui MT, Yu MH, Havsteen B, Commenges D, Weissenbach J, Schwinger E, Gottesman II, Pakstis AJ, Wetterberg L, Kidd KK, Helgason T. 1995. An international two-stage genome-wide search for schizophrenia susceptibility genes. Nat Genet 11:321-324.
20. Nurnberger JI Jr, Blehar MC, Kaufmann CA, York-Cooler C, Simpson SG, Harkavy-Friedman J, Severe JB, Malaspina D, Reich T. 1994. Diagnostic interview for genetic studies. Rationale, unique features, and training. NIMH Genetics Initiative. Arch Gen Psychiatry 51:849-859.
21. Ordentlich P, Yan Y, Zhou S, Heyman RA. 2003. Identification of the antineoplastic agent 6-mercaptopurine as an activator of the orphan nuclear hormone receptor Nurr1. J Biol Chem 278:24791-24799.
22. Perlmann T, Jansson L. 1995. A novel pathway for vitamin A signaling mediated by RXR heterodimerization with NGFI-B and NURR1. Genes Dev 9:769-782.
23. Rios DL, Vargas AF, Torres MR, Zago AJ, Callegari-Jacques SM, Hutz MH. 2003. Interaction between SREBP-1a and APOB polymorphisms influences total and low-density lipoprotein cholesterol levels in patients with coronary artery disease. Clin Genet 63:380-385.
24. Sacchetti P, Mitchell TR, Granneman JG, Bannon MJ. 2001. Nurr1 enhances transcription of the human dopamine transporter gene through a novel mechanism. J Neurochem 76:1565-1572.
25. Sakurada K, Ohshima-Sakurada M, Palmer TD, Gage FH. 1999. Nurr1, an orphan nuclear receptor, is a transcriptional activator of endogenous tyrosine hydroxylase in neural progenitor cells derived from the adult brain. Development 126:4017-4026.
26. Samad TA, Krezel W, Chambon P, Borrelli E. 1997. Regulation of dopaminergic pathways by retinoids: Activation of the D2 receptor promoter by members of the retinoic acid receptor-retinoid X receptor family. Proc Natl Acad Sci USA 94:14349-14354.
27. Saucedo-Cardenas O, Quintana-Hau JD, Le WD, Smidt MP, Cox JJ, De Mayo F, Burbach JP, Conneely OM. 1998. Nurr1 is essential for the induction of the dopaminergic phenotype and the survival of ventral mesencephalic late dopaminergic precursor neurons. Proc Natl Acad Sci USA 95:4013-4018.
28. Torii T, Kawarai T, Nakamura S, Kawakami H. 1999. Organization of the human orphan nuclear receptor Nurr1 gene. Gene 230:225-232.
29. Tseng KY, Roubert C, Do L, Rubinstein M, Kelly MA, Grandy DK, Low MJ, Gershanik OS, Murer MG, Giros B, Raisman-Vozari R. 2000. Selective increase of Nurr1 mRNA expression in mesencephalic dopaminergic neurons of D2 dopamine receptor-deficient mice. Brain Res Mol Brain Res 80:1-6.
30. Tsuang MT, Stone WS, Faraone SV. 2001. Genes, environment and schizophrenia. Br J Psychiatry 40:s1S-s24.
31. Vidal-Puig A, Moller DE. 1994. Comparative sensitivity of alternative single-strand conformation polymorphism (SSCP) methods. Biotechniques 17:490-496.
32. Wang Z, Benoit G, Liu J, Prasad S, Aarnisalo P, Liu X, Xu H, Walker NP, Perlmann T. 2003. Structure and function of Nurr1 identifies a class of ligand-independent nuclear receptors. Nature 423:555-560.
33. Williams NM, Rees MI, Holmans P, Norton N, Cardno AG, Jones LA, Murphy KC, Sanders RD, McCarthy G, Gray MY, Fenton I, McGuffin P, Owen MJ. 1999. A two-stage genome scan for schizophrenia susceptibility genes in 196 affected sibling pairs. Hum Mol Genet 8:1729-1739.
34. Zetterström RH, Williams R, Perlmann T, Olson L. 1996. Cellular expression of the immediate early transcription factors Nurr1 and NGFI-B suggests a gene regulatory role in several brain regions including the nigrostriatal dopamine system. Brain Res Mol Brain Res 41:111-120.
35. Zetterström RH, Solomin L, Jansson L, Hoffer BJ, Olson L, Perlmann T. 1997. Dopamine neuron agenesis in Nurr1-deficient mice. Science 276:248-250.